Lumedica

Lumedica is a biotechnology company based in Durham, North Carolina, that develops low-cost, high-performance Optical Coherence Tomography (OCT) imaging technologies. The company was founded in 2014 by Dr. Adam Wax and Dr. William Brown with a mission to provide affordable and accessible imaging solutions for research, industrial, and clinical applications worldwide.

The company's primary goal is to decrease the cost of optical coherence tomography systems, which currently range from $35,000 to $150,000 in the global market. Lumedica aims to make this advanced imaging technology more affordable for a wider range of applications.

Lumedica offers a product line called OQ LabScope 3.0, which features speeds up to 80,000 A/scans per second and resolutions down to 2 microns. Another product, the OQ Stratascope, was launched in 2019 and utilizes a 1310 nm light source for deeper imaging in highly scattering samples.

The company has a pending FDA application for the OQ Eyescope 1.0 /X specifically for retinal imaging. Additionally, they are actively developing OCT systems for other clinical applications including dermatology, dental, oncology, and intra-surgical use.

Lumedica has established a network of premier distributors in South Korea, Taiwan, Hong Kong, and Mainland China. They also work with distributors in Japan, the EU, India, and China to reach more than 20 countries around the world.

The company's headquarters are located at 404 Hunt Street, Suite 510, Durham, NC 27701. You can reach them via the business phone number (919) 244-2128 or by sending an email to info@lumedica.com.

According to the Trustburn listing, Lumedica has a rating of 4.3 out of 5 stars from 7 reviews. The rating split includes five 5-star reviews, two 4-star reviews, and one 3-star review, all posted between April 2023 and November 2023.

Reviewers consistently praise Lumedica for providing top-notch services and advanced technology that significantly improves patient outcomes and care. Many customers describe the level of service as exceptional and professional, noting that the company exceeded their expectations.

Some reviewers mention that Lumedica's products and services have greatly benefited their patients and improved overall patient care. Users frequently highlight the company's expertise and the high quality of their medical solutions.

Lumedica has been in operation since 2014, celebrating a decade of affordable and quality imaging. They launched their first research OCT system, OQ Labscope 1.0, in 2017 with a price of $9,995.

The company is currently funded by grants from the NIH and the State of North Carolina. They have a proven track record in scientific innovation, product development, and both private and public fundraising.

Lumedica specializes in optical imaging devices and focuses on creating affordable, easy-to-use imaging technologies. Their mission is to provide high-quality imaging solutions that are accessible for various needs.

Lumedica distinguishes itself by offering OCT systems at a fraction of the cost of current market leaders, which range from $35,000 to $150,000. They aim to make this gold-standard eye disease imaging technology more accessible for early detection before symptoms appear.

The company's technology allows healthcare professionals to detect disease earlier, often before there is a single symptom. This capability is central to their value proposition for both clinical and research applications.

The official website of Lumedica is lumedicasystems.com.